Neurocognitive consequences of HIV in southern India: A preliminary study of clade C virus

Journal of the International Neuropsychological Society

Volumn 12, Issue 3, 2006, Pages 424-430

  Yepthomi, Tokugha ^a   Paul, Robert ^b,d   Vallabhaneni, Snigdha ^c   Kumarasamy, N ^a   Tate, David F ^b   Solomon, Suniti ^a   Flanigan, Timothy ^c  

^a YRG CENTRE FOR AIDS RESEARCH AND EDUCATION   (India)

^b Brown University Centers for Behavioral and Preventive Medicine   (United States)

^c BROWN UNIVERSITY   (United States)

^d BUTLER HOSPITAL   (United States)

Author keywords

Clade C; Cognition; Dementia; HIV

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ADULT; ARTICLE; BRAIN FUNCTION; CLADISTICS; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEOGRAPHIC DISTRIBUTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; MALE; MENTAL PERFORMANCE; MENTAL TASK; POPULATION DISTRIBUTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VIRUS STRAIN; WESTERN BLOTTING;

ADULT; ANTIGENS, CD4; BRAIN; COGNITION DISORDERS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INDIA; MALE; NEUROPSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX;

EID: 33745661401     PISSN: 13556177     EISSN: 14697661     Source Type: Journal    
DOI: 10.1017/S1355617706060516     Document Type: Article

References (23)

1. Andras, I.E., Pu, H., Deli, M.A., Nath, A., Hennig, B., & Toborek, M. (2003). HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells. Journal of Neuroscience Research, 74, 255-265.
2. Benedict, R. (1997). Brief Visuospatial Memory Test-Revised. Odessa, FL: Psychological Assessment Resources.
3. Brandt, J. (1991). The Hopkins Verbal Learning Test: Development of a new verbal memory test with six equivalent forms. The Clinical Neuropsychologist, 5, 125-142.
4. Centlivre, M., Sommer, P., Michel, M., Fang, R., Gofflo, S., Valladeau, J., Scmitt, N., Thierry, F., Hurtrel, F., Wain-Hobson, S., & Sala, M. (2005). HIV-1 clade promoters strongly influence spatial and temporal dynamics of viral replication in vivo. Journal of Clinical Investigation, 115, 348-358.
5. Cohen, R., Boland, R., Paul, R., Tashima, K., Schoenbaum, E., Celentano, D., Schuman, P., Smith, D.K., & Carpenter, C.C. (2001). Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women. AIDS, 15, 341-345.
6. Das Gupta, J., Kumar, K.G., Rao, S.L., Wilkie, F.L., Waldrop-Valverde, D., Subbakrishna, D.K., Desai, A., Ravi, V., Rao, B.S., Satish, K.S., Kumar, M., & Satishchandra, P. (2005). Cognitive deficits in neurologically asymptomatic HIV-seropositive adults: A study from South India. Poster presented at the HIV Infection and the Central Nervous System: Developed and Resource Limited Settings conference, Frascati, Italy.
7. Golden, C.J. (1978). Stroop Color and Word Test: A manual for clinical and experimental uses. Wood Dale, IL: Stoelting.
8. Grant, I., Heaton, R., & Atkinson, J. (1995). Neurocognitive disorders in HIV-1 infection. HNRC Group. HIV Neurobehavioral Research Center. Current Topics in Microbiology and Immunology, 202, 11-32.
9. Grossman, Z., Vardinon, N., Chemtob, D., Alkan, M., Bentwich, Z., Burke, M., Gottesman, G., Istomin, V., Levi, I., Maayan, S., Shahar, E., Schapiro, J.M., & the Israel Multi-Center Study Group (2001). Genotypic variation of HIV-1 reverse transcriptase and protease: Comparative analysis of clade C and clade B. AIDS, 15, 1453-1460.
10. Heaton, R., Marcotte, T., Mindt, M., Sadek, J., Moore, D., Bentley, H., McCutchan, J.A., Reicks, C., Grant, I., & HNRC Group. (2004). The impact of HIV-associated neuropsychological impairment on everyday functioning. Journal of the International Neuropsychological Society, 10, 317-331.
11. Kantor, R., Zijenah, L., Shafer, R., Mutetwa, S., Johnston, E., Lloyd, R., von Lieven, A., Israilski, D., & Katzenstein, D.A. (2002). HIV-1 subtype C reverse transcriptase and protease genotypes in Zimbabwean patients failing antiretroviral therapy. AIDS Research Human Retroviruses, 18, 1407-1413.
12. Lojek, E. & Bornstein, R.A. (2005). The stability of neurocognitive patterns in HIV infected men: Classification considerations. Journal of Clinical and Experimental Neuropsychology, 27, 665-682.
13. Maj, M., D'Elia, L., & Satz, P. (1993). Evaluation of two new neuropsychological tests designed to minimize cultural bias in the assessment of HIV-1 seropositive persons: A WHO study. Archives of Clinical Neuropsychology, 8, 123-135.
14. Maj, M., Janssen, R., Starace, F., Zaudig, M., Satz, P., Sughondhabirom, B., Luabeya, M.A., Riedel, R., Ndetei, D., & Calil, H.M. (1994a). WHO Neuropsychiatric AIDS study, cross-sectional phase I: Study design and psychiatric findings. Archives of General Psychiatry, 51, 39-49.
15. Maj, M., Satz, P., Janssen, R., Zaudig, M., Starace, F., D'Elia, L., Sughondhabirom, B., Mussa, M., Naber, D., & Ndetei, D. (1994b). WHO Neuropsychiatric AIDS study, cross-sectional phase II: Neuropsychological and neurological findings. Archives of General Psychiatry, 51, 51-61.
16. Matthews, C. & Klove, H. (1964). Instruction Manual for the Adult Neuropsychology Test Battery. Madison, WI: University of Wisconsin Medical School.
17. Paul, R.H., Cohen, R.A., & Stern, R.A. (2002). Neurocognitive manifestations of human immunodeficiency virus. CNS Spectrums, 7, 860-866.
18. Pu, H., Tian, J., Flora, G., Lee, Y.W., Nath, A., Hennig, B., & Toborek, M. (2003). HIV-1 Tat protein upregulates inflammatory mediators and induces monocyte invasion into the brain. Molecular Cell Neuroscience, 24, 224-237.
19. Ranga, U., Shankarappa, R., Siddappa, N., Ramakrishna, L., Nagendran, R., Mahalingam, M., Mahadevan, A., Jayasuryan, N., Satishchandra, P., Shankar, S.K., & Prasad, V.R. (2004). Tat protein of human immunodeficiency virus type 1 subtype C strains is a defective chemokine. Virology, 78, 2586-2590.
20. Robertson, K., Robertson, W., Ford, S., Watson, D., Fiscus, S., Harp, A., & Hall, C.D. (2004). Highly active antiretroviral therapy improves neurocognitive functioning. Journal of Acquired Immune Deficiency Syndrome, 36, 562-566.
21. Satishchandra, P., Nalini, A., Gourie-Devi, M., Khanna, N., Santosh, V., Ravi, V., Desai, A., Chandramuk, A., Jayakumar, P.N., & Shankar, S.K. (2000). Profile of neurologic disorders associated with HIV/AIDS from Bangalore, South India (1989-96). Indian Journal of Medical Research, 111, 14-23.
22. Simpson, D. (1999). Human immunodeficiency virus-associated dementia: Review of pathogenesis, prophylaxis, and treatment studies of zidovudine therapy. Clinical Infectious Diseases, 29, 19-34.
23. Wadia, R., Pujari, S., Kothari, S., Udhar, M., Kulkarni, S., Bhagat, S., & Nanivadekar, A. (2001). Neurological manifestations of HIV disease. Journal of the Association of Physicians India, 49, 343-348.